...million) up front, plus up to CHF150 million ($162.1 million) in regulatory milestones. Endosense developed TactiCath...
...with a PMA submission expected by year end. St. Jude said it plans to integrate TactiCath...

...EndoSense began the U.S. and European pivotal TOCCASTAR trial to compare its TactiCath force-sensing ablation catheter...
...The product has CE Mark approval in the EU. Endosense S.A. , Geneva, Switzerland Product: TactiCath...